IL7Rα expression and upregulation by IFNβ in dendritic cell subsets is haplotype-dependent.
The IL7Rα gene is unequivocally associated with susceptibility to multiple sclerosis (MS). Haplotype 2 (Hap 2) confers protection from MS, and T cells and dendritic cells (DCs) of Hap 2 exhibit reduced splicing of exon 6, resulting in production of relatively less soluble receptor, and potentially m...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3797747?pdf=render |
id |
doaj-31ed427fd32c4fc3be012982a02f12e8 |
---|---|
record_format |
Article |
spelling |
doaj-31ed427fd32c4fc3be012982a02f12e82020-11-25T01:20:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01810e7750810.1371/journal.pone.0077508IL7Rα expression and upregulation by IFNβ in dendritic cell subsets is haplotype-dependent.Fiona C McKayEdwin HoeGrant ParnellPrudence GattStephen D SchibeciGraeme J StewartDavid R BoothThe IL7Rα gene is unequivocally associated with susceptibility to multiple sclerosis (MS). Haplotype 2 (Hap 2) confers protection from MS, and T cells and dendritic cells (DCs) of Hap 2 exhibit reduced splicing of exon 6, resulting in production of relatively less soluble receptor, and potentially more response to ligand. We have previously shown in CD4 T cells that IL7Rα haplotypes 1 and 2, but not 4, respond to interferon beta (IFNβ), the most commonly used immunomodulatory drug in MS, and that haplotype 4 (Hap 4) homozygotes have the highest risk of developing MS. We now show that IL7R expression increases in myeloid cells in response to IFNβ, but that the response is haplotype-dependent, with cells from homozygotes for Hap 4 again showing no response. This was shown using freshly derived monocytes, in vitro cultured immature and mature monocyte-derived dendritic cells, and by comparing homozygotes for the common haplotypes, and relative expression of alleles in heterozygotes (Hap 4 vs not Hap 4). As for T cells, in all myeloid cell subsets examined, Hap 2 homozygotes showed a trend for reduced splicing of exon 6 compared to the other haplotypes, significantly so in most conditions. These data are consistent with increased signaling being protective from MS, constitutively and in response to IFNβ. We also demonstrate significant regulation of immune response, chemokine activity and cytokine biosynthesis pathways by IL7Rα signaling in IFNβ -treated myeloid subsets. IFNβ-responsive genes are over-represented amongst genes associated with MS susceptibility. IL7Rα haplotype may contribute to MS susceptibility through reduced capacity for IL7Rα signalling in myeloid cells, especially in the presence of IFNβ, and is currently under investigation as a predictor of therapeutic response.http://europepmc.org/articles/PMC3797747?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Fiona C McKay Edwin Hoe Grant Parnell Prudence Gatt Stephen D Schibeci Graeme J Stewart David R Booth |
spellingShingle |
Fiona C McKay Edwin Hoe Grant Parnell Prudence Gatt Stephen D Schibeci Graeme J Stewart David R Booth IL7Rα expression and upregulation by IFNβ in dendritic cell subsets is haplotype-dependent. PLoS ONE |
author_facet |
Fiona C McKay Edwin Hoe Grant Parnell Prudence Gatt Stephen D Schibeci Graeme J Stewart David R Booth |
author_sort |
Fiona C McKay |
title |
IL7Rα expression and upregulation by IFNβ in dendritic cell subsets is haplotype-dependent. |
title_short |
IL7Rα expression and upregulation by IFNβ in dendritic cell subsets is haplotype-dependent. |
title_full |
IL7Rα expression and upregulation by IFNβ in dendritic cell subsets is haplotype-dependent. |
title_fullStr |
IL7Rα expression and upregulation by IFNβ in dendritic cell subsets is haplotype-dependent. |
title_full_unstemmed |
IL7Rα expression and upregulation by IFNβ in dendritic cell subsets is haplotype-dependent. |
title_sort |
il7rα expression and upregulation by ifnβ in dendritic cell subsets is haplotype-dependent. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
The IL7Rα gene is unequivocally associated with susceptibility to multiple sclerosis (MS). Haplotype 2 (Hap 2) confers protection from MS, and T cells and dendritic cells (DCs) of Hap 2 exhibit reduced splicing of exon 6, resulting in production of relatively less soluble receptor, and potentially more response to ligand. We have previously shown in CD4 T cells that IL7Rα haplotypes 1 and 2, but not 4, respond to interferon beta (IFNβ), the most commonly used immunomodulatory drug in MS, and that haplotype 4 (Hap 4) homozygotes have the highest risk of developing MS. We now show that IL7R expression increases in myeloid cells in response to IFNβ, but that the response is haplotype-dependent, with cells from homozygotes for Hap 4 again showing no response. This was shown using freshly derived monocytes, in vitro cultured immature and mature monocyte-derived dendritic cells, and by comparing homozygotes for the common haplotypes, and relative expression of alleles in heterozygotes (Hap 4 vs not Hap 4). As for T cells, in all myeloid cell subsets examined, Hap 2 homozygotes showed a trend for reduced splicing of exon 6 compared to the other haplotypes, significantly so in most conditions. These data are consistent with increased signaling being protective from MS, constitutively and in response to IFNβ. We also demonstrate significant regulation of immune response, chemokine activity and cytokine biosynthesis pathways by IL7Rα signaling in IFNβ -treated myeloid subsets. IFNβ-responsive genes are over-represented amongst genes associated with MS susceptibility. IL7Rα haplotype may contribute to MS susceptibility through reduced capacity for IL7Rα signalling in myeloid cells, especially in the presence of IFNβ, and is currently under investigation as a predictor of therapeutic response. |
url |
http://europepmc.org/articles/PMC3797747?pdf=render |
work_keys_str_mv |
AT fionacmckay il7raexpressionandupregulationbyifnbindendriticcellsubsetsishaplotypedependent AT edwinhoe il7raexpressionandupregulationbyifnbindendriticcellsubsetsishaplotypedependent AT grantparnell il7raexpressionandupregulationbyifnbindendriticcellsubsetsishaplotypedependent AT prudencegatt il7raexpressionandupregulationbyifnbindendriticcellsubsetsishaplotypedependent AT stephendschibeci il7raexpressionandupregulationbyifnbindendriticcellsubsetsishaplotypedependent AT graemejstewart il7raexpressionandupregulationbyifnbindendriticcellsubsetsishaplotypedependent AT davidrbooth il7raexpressionandupregulationbyifnbindendriticcellsubsetsishaplotypedependent |
_version_ |
1725131847230291968 |